In silico evaluation of berberine and silymarin against metabolic targets: a rationale for OMICS technology-based co-formulation
Crossref DOI link: https://doi.org/10.1007/s40203-025-00426-1
Published Online: 2025-09-17
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Amalraj, Augustine
Narayanan, V. Anantha
Ardra, T. S.
Gopi, Sreeraj
Text and Data Mining valid from 2025-09-17
Version of Record valid from 2025-09-17
Article History
Received: 21 July 2025
Accepted: 1 September 2025
First Online: 17 September 2025
Declarations
:
: The authors declare no competing interests.